Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

t(2;2)(p23;q13)

Clinics and Pathology

Disease Inflammatory myofibroblastic tumors (IMT)
Clinics rare soft tissue tumour found in children and young adults
Pathology spindle cell proliferation with myofibroblastic differenciation and an inflammatory infiltrate; staining of ALK-positive cases, representing 60% of IMT cases, is usually confined to the cytoplasm, but it showed a nuclear membran pattern in one of the two t(2;2) available cases
Prognosis Inflammatory myofibroblastic tumors have a low malignant potential and good prognosis; however, the 2 cases with a t(2;2) showed (relatively) aggressive clinical course with tumor recurrence and round cell transformation

Genes involved and Proteins

Gene Name ALK
Location 2p23
Protein 1620 amino acids; 177 kDa; glycoprotein (200 kDa mature protein) ; membrane associated tyrosine kinase receptor

Gene Name RANBP2
Location 2q13
Protein 3224 amino acids; nuclear pore protein involved in nuclear export

Result of the chromosomal anomaly

Hybrid Gene
Description 5' RANBP2 - 3' ALK
Fusion Protein
Description 1430 amino acids; 6867 N-term amino acid from RANBP2, fused to the 562 C-term amino acids from ALK (i.e. the leucine-rich domain, including the leucine zipper, of RANBP2 and the entire cytoplasmic portion of ALK with the tyrosine kinase domain).
Oncogenesis the leucine zipper of RANBP2 could mediate oligomerization of RANBP2-ALK
  

Bibliography

 
Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.
Griffin CA, Hawkins AL, Dvorak C, Henkle C, Ellingham T, Perlman EJ.
Cancer Res 1999, 59: 2776-2780.
 
Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogen,ic mechanims?
Ladanyi M.
Am J Pathol 2000; 157: 341-345.
 
Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor.
Ma Z, Hill DA, Collins MH, Morris SW, Sumegi J, Zhou M, Zuppan C, Bridge JA.
Genes Chromosomes Cancer 2003; 37: 98-105.
PMID 12661011
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Contributor(s)

Written08-2003Jean-Loup Huret

Citation

This paper should be referenced as such :
Huret JL . t(2;2)(p23;q13). Atlas Genet Cytogenet Oncol Haematol. August 2003 .
URL : http://AtlasGeneticsOncology.org/Tumors/t0202p23q13ID5214.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Thu Apr 17 14:15:04 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.